Appointment booking for Dr. Pushpalatha Arakere, MD is currently not available.Dr. Pushpalatha Arakere, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Pushpalatha Arakere, MD (she/her) is a Infectious Disease Doctor in Fresno, CA with over 18 years of experience. What is your opinion of Dr. Pushpalatha Arakere, MD? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Pushpalatha Arakere, MD has received over $2,565 which includes payments from the following companies:
$555.44 from EMD Serono, Inc.
$533.82 from Merck Sharp & Dohme Corporation
$446.09 from Gilead Sciences Inc
$283.41 from Janssen Biotech, Inc.
$165.71 from Insmed, Inc.
$103.33 from ViiV Healthcare Company
$102.68 from Allergan Inc.
$89.99 from Janssen Products, LP
$80.04 from Theratechnologies Inc.
$41.86 from Takeda Pharmaceuticals U.S.A., Inc.
$37.55 from Melinta Therapeutics, Inc.
$30.93 from Paratek Pharmaceuticals, Inc.
$24.02 from Respiratory Technologies, Inc.
$23.01 from TETRAPHASE PHARMACEUTICALS, INC.
$16.76 from Durata Therapeutics Inc.
$15.73 from Philips Electronics North America Corporation
$14.69 from Pfizer Inc.
Payments received by Dr. Pushpalatha Arakere, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!